Ag Novartis, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), sold 634,692 shares at $1.01 ($627K) on 2019-03-26, disclosed to the SEC on 2019-03-28.
Open-market sale of $627k ARPO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 177,762 | $180K | 28.7% |
| 2 | $1.01 | 177,762 | $180K | 28.7% |
| 3 | $0.99 | 50,749 | $50K | 8.0% |
| 4 | $0.99 | 50,749 | $50K | 8.0% |
| 5 | $0.94 | 88,835 | $84K | 13.3% |
| 6 | $0.94 | 88,835 |
| $84K |
| 13.3% |
| Total | $0.99 avg | 634,692 | $627K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |